<DOC>
	<DOCNO>NCT00990145</DOCNO>
	<brief_summary>This Phase I , single-center , randomize , double-blind , placebo-controlled , ascend multiple dose study evaluate safety , tolerability , pharmacokinetics orally administer EDP-322 healthy adult volunteer .</brief_summary>
	<brief_title>Multiple Ascending-Dose Study EDP 322 Healthy Adult Volunteers</brief_title>
	<detailed_description>Fifty-two subject enrol 6 cohort . Six subject cohort randomize receive EDP-322 2 subject cohort receive placebo . Each cohort receive study drug daily ( QD ) 7 day feed condition . Multiple oral dos EDP 322 range 200 800 mg safe generally well tolerate healthy male female subject study .</detailed_description>
	<criteria>Healthy adult male females 18 45 year age Females eligible documentation exist surgically sterilize In good general health [ determine medical history , physical examination , clinical laboratory test , without evidence clinically significant abnormality , opinion investigator medical monitor . Subject rest 12lead ECG screening show clinically significant abnormality Bazettcorrected QT interval le 450 millisecond . BMI 1832 kg/m2 Subject read , understood , sign ICF History chronic recurrent renal , hepatic , pulmonary , allergic , cardiovascular , gastrointestinal , endocrine , CNS , hematologic metabolic disease , immunologic , emotional , and/or psychiatric disturbance . History gastric surgery , etc . Abnormality clinical lab test result Screening considered clinical significant investigator medical monitor . Gastroenteritis within 1 week Day 1 . Acute illness could pose threat harm subject interfere laboratory test result interpretation study data . Donated blood within 4 week period Day 1 . Positive Hep B , C HIV1 , HIV=2 , positive result Screening hepatitis B surface antigen ( HBsAG ) , HCV antibody , HIV1 HIV2 antibody Medicationrelated exclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>